For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies researching your condition/s 11

Based on the information you provided, you may be eligible for the following studies researching your condition/s.

  • Three arm randomized open-label Phase II study of radium-223 dichloride in subjects with castration-resistant prostate cancer metastatic to the bone The goal of this study is to figure out whether it is safe to use a higher dose of radium-223 dichloride than the FDA approved dose of 50 kBq per kilogram of weight, and, whether it is safe and effective to use the approved dose for up to 12 doses, instead of up to 6 doses as FDA approved. This study is researching all of the following topics: Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Improving Adherence to Oral Cancer Agents and Self-Care of Symptoms Using an IVR The purpose of the study is to: (1) determine if daily reminders will help patients take their anti-cancer pills as prescribed and; (2) test strategies to manage symptoms between doctor office visits. We are hoping to learn better ways to support patients who are prescribed oral anti-cancer pills. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Melanoma Pancreatic cancer Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • A Randomized Phase II Study of Androgen Deprivation Therapy with or without PD 0332991 in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer The study purpose is to compare the effectiveness and safety of androgen deprivation therapy (LHRH agonist + bicalutamide) alone vs. androgen deprivation therapy in combination with study drug PD0332991 (palbociclib) in subjects with RB-positive metastatic hormone-sensitive prostate cancer. This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • IMPACT Study (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and controls). The IMPACT Study is an international research study designed to look at methods of early detection of prostate cancer in men at a higher risk due to the presence of known harmful alterations in mismatch repair genes, Lynch Syndrome (hereditary non– polyposis colorectal cancer or HNPCC). This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • 40 years to 69 years
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1b, Open-label Study of Oral BGJ398 in Combination with Oral BYL719 in Adult Patients with Select Advanced Solid Tumors This clinical research study is to determine how much of experimental drugs BGJ398 and BYL719 can safely be given in combination to patients. Researchers would like to know how much of these two drugs can be given without causing serious side effects and also how these two drugs affect your body. This study is researching all of the following topics: Brain cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase Ib, Open Label, Dose Escalation Study of the Safety and Pharmacology of GDC 0068 in Combination with Docetaxel and Enzalutamde in Patients with Advanced Solid Tumors The purpose of this study is to test the safety of an experimental drug, GDC 0068, at different dose levels, given in combination with other cancer drugs in patients with different types of cancers, and to find out what effects these combinations of drugs have on cancer patients. This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • PROSPER:A Multinational,Phase 3, Randomized,Double-Blind,Placebo-Controlled,Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer The study will help determine if enzalutamide may be a potential treatment for men with your type of prostate cancer, using several different tests to determine if adding enzalutamide to your current treatment of surgical castration or hormone therapy is better than your current treatment alone. This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • SWOG S1216 "A Phase III Randomized Trial Comparing Androgen Deprivation Therapy (ADT) + TAK-700 With ADT + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer." The purpose of this study is to find out what effects (good and/or bad) there are to adding the new investigational drug TAK-700 (also called orteronel) to standard hormone therapy which is used to treat prostate cancer as compared to the standard of hormone therapy alone. This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • RTOG 1115 Phase III Trial of Dose Escalated Radiation Therapy and Androgen Deprivation with or without TAK-700 in Men with High Risk Prostate Cancer This study looks at the effects of hormone therapy + an investigational drug + radiation therapy compared against hormone therapy + radiation therapy to find out which is better. This study is researching all of the following topics: Prostate cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
Showing 1-10 of 11 studies
Show more studies

Studies researching other conditions 66

You may also be eligible for the following studies researching other conditions, either as a volunteer with condition/s or as a healthy volunteer.